{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:32:24Z","timestamp":1762101144670,"version":"3.41.2"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/igc.0b013e3181a83e1a","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:48:52Z","timestamp":1291384132000},"page":"1377-1383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Kallikrein 4 Overexpression in Endometrial Carcinoma and Upregulation by Estrogen via Mitogen-Activated Protein Kinase Signal Pathway"],"prefix":"10.1016","volume":"19","author":[{"given":"Shu-quan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-yan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0005","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0010","first-page":"2363","article-title":"Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas","volume":"7","author":"Dong","year":"2001","journal-title":"Clin Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0015","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1210\/jcem.86.5.7625","article-title":"Kallikrein 4 (KLK4), a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometrial cancer cell line","volume":"86","author":"Myers","year":"2001","journal-title":"KLE. J Clin Endocrinol Metab."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0020","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1158\/0008-5472.CAN-06-4728","article-title":"Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer","volume":"67","author":"Klokk","year":"2007","journal-title":"Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1515\/BC.2006.092","article-title":"Human tissue kallikrein 9: production of recombinant proteins and specific antibodies","volume":"387","author":"Memari","year":"2006","journal-title":"Biol Chem."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/BC.2001.002","article-title":"The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions","volume":"382","author":"Clements","year":"2001","journal-title":"Biol Chem."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0035","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1158\/0008-5472.CAN-03-2025","article-title":"Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer","volume":"64","author":"Xi","year":"2004","journal-title":"Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/104454901750361497","article-title":"Distinctly different gene structure of KLK4\/KLK-L1\/prostase\/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones","volume":"20","author":"Korkmaz","year":"2001","journal-title":"DNA Cell Biol."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1373\/clinchem.2004.042341","article-title":"Intron retention: a common splicing event within the human kallikrein gene family","volume":"51","author":"Michael","year":"2005","journal-title":"Clin Chem."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1677\/erc.1.01062","article-title":"Compartmentalized expression of kallikrein 4 (KLK4\/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms","volume":"12","author":"Dong","year":"2005","journal-title":"Endocr Relat Cancer."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0055","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1373\/clinchem.2005.049692","article-title":"Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids","volume":"51","author":"Obiezu","year":"2005","journal-title":"Clin Chem."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000101311","article-title":"Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases","volume":"185","author":"Lawrence","year":"2007","journal-title":"Cells Tissues Organs."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1515\/BC.2006.089","article-title":"The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition","volume":"387","author":"Whitbread","year":"2006","journal-title":"Biol Chem."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1677\/erc.1.00958","article-title":"Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells","volume":"12","author":"Veveris-Lowe","year":"2005","journal-title":"Endocr Relat Cancer."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2004.03.044","article-title":"Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer","volume":"94","author":"Xi","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/pros.20465","article-title":"Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer","volume":"67","author":"Gao","year":"2007","journal-title":"Prostate."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.09.024","article-title":"Human tissue kallikrein gene family: applications in cancer","volume":"224","author":"Obiezu","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cyto.2008.02.002","article-title":"Mitogen activated protein kinase (MAPK) mediates non-genomic pathway of estrogen on T cell cytokine production following trauma-hemorrhage","volume":"42","author":"Suzuki","year":"2008","journal-title":"Cytokine."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0095","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0961203307087982","article-title":"Extracellular signal-regulated kinase 1\/2 signalling in SLE T cells is influenced by oestrogen and disease activity","volume":"17","author":"Gorjestani","year":"2008","journal-title":"Lupus."},{"key":"10.1111\/IGC.0b013e3181a83e1a_bb0100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/dneu.20609","article-title":"PI3 kinase\/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson\u2019s disease","volume":"68","author":"Quesada","year":"2008","journal-title":"Dev Neurobiol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181a83e1a","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:34:54Z","timestamp":1753101294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24028147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1048891X24028147"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181a83e1a","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kallikrein 4 Overexpression in Endometrial Carcinoma and Upregulation by Estrogen via Mitogen-Activated Protein Kinase Signal Pathway","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181a83e1a","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}